Relapsed or Refractory B-cell Lymphomas
1 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma (NCT03576807) | Xin Wang | 2018-04-04 |
Track Relapsed or Refractory B-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.